引用本文
  • 涂秋杰,任涛.β-arrestin 2 shRNA慢病毒载体的构建及鉴定[J].同济大学学报(医学版),2017,38(6):33-36, 40.    [点击复制]
  • TU Qiu-jie,REN Tao.Construction and verification of a lentivector for beta arrestin 2 short hairpin RNA[J].同济大学学报(医学版),2017,38(6):33-36, 40.   [点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 684次   下载 585 本文二维码信息
码上扫一扫!
β-arrestin 2 shRNA慢病毒载体的构建及鉴定
涂秋杰,任涛
0
(同济大学附属东方医院呼吸内科,上海 200120)
摘要:
目的 构建β-arrestin 2的shRNA慢病毒载体,获得稳定低表达β-arrestin 2的人非小细胞肺癌A549细胞并验证敲低效果。方法 查询4对可信的β-arrestin 2敲低序列,将载体质粒pSicoR-GFP线性化,构建目的质粒,转化感受态细胞,对长出的克隆应用菌落PCR鉴定,再对阳性结果进行测序和比对分析。重组病毒质粒与另外三种辅助包装原件载体质粒通过Lipofectamine 2000共转染293T细胞,培养48h后,收集细胞培养上清液,导入人非小细胞肺癌细胞A549中,用qRT-PCR检测转染效率。结果 成功构建β-arrestin 2的shRNA慢病毒载体质粒,测序比对结果一致。qRT-PCR检测发现一组β-arrestin 2的mRNA表达只有对照组的56%。结论 成功构建β-arrestin 2的shRNA慢病毒载体,并验证其在人非小细胞肺癌细胞A549中敲低效果显著。
关键词:  β-arrestin 2  shRNA  慢病毒  非小细胞肺癌
DOI:10.16118/j.1008-0392.2017.06.007
投稿时间:2017-04-10
基金项目:上海市浦东新区卫生系统重点学科建设项目(PWZx2014-10)
Construction and verification of a lentivector for beta arrestin 2 short hairpin RNA
TU Qiu-jie,REN Tao
(Dept. of Respiratory Medicine, East Hospital, Tongji University, Shanghai 200120, China)
Abstract:
Objective To construct and verify the β-arrestin 2 shRNA lentivector. Methods Four credible β-arrestin 2 knock-down sequences were searched. The linearized lentiviral vector pSicoR-GFP and shRNAs were constructed into aim plasmid pSicoR-shRNA under the effect of In-Fusion convertase. The aim plasmids were transfected into competent cells. The grown colonies were identified by colony PCR, and then the positive colonies were sequenced. Aligned recombinant lentivector plasmids and the other three helping plasmids were cotransfected into 293T cells by Lipofectamine 2000, and cell culture supernatant after 48h of culture was collected to treat human non-small cell lung cancer cells A549, then the transfection efficiency was detected by qRT-PCR. Results β-arrestin shRNA lentivirus vector plasmid was constructed successfully, and the sequencing comparison results were consistent. qRT-PCR showed that one group of the β-arrestin 2 expression was only 56% of the control group. Conclusion The β-arrestin 2 shRNA lentivector has been successfully constructed and its knock-down efficiency was verified in human non-small cell lung cancer cells A549.
Key words:  β-arrestin 2  shRNA  lentivirus vector  non-small cell lung cancer

您是第5108790位访问者
版权所有《同济大学学报(医学版)》编辑部
主管单位:教育部 主办单位:同济大学
地  址: 上海四平路1239号 邮编:200092 电话:021-65980705 E-mail: yxxb@tongji.edu.cn
本系统由北京勤云科技发展有限公司设计